Your browser doesn't support javascript.
loading
Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab.
Wang, Yong; Xu, Jun; Luo, Ningning; Qi, Chuang; Tao, Rongjie.
Afiliación
  • Wang Y; Shandong Cancer Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Xu J; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Luo N; Department of Neurosurgery, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
  • Qi C; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Tao R; The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
Invest New Drugs ; 39(5): 1432-1435, 2021 10.
Article en En | MEDLINE | ID: mdl-33851364
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ftalazinas / Piperazinas / Neoplasias Encefálicas / Bevacizumab / Antineoplásicos Inmunológicos / Glioma Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ftalazinas / Piperazinas / Neoplasias Encefálicas / Bevacizumab / Antineoplásicos Inmunológicos / Glioma Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: China